Mostrar el registro sencillo del ítem

dc.contributor.authorMorales Pérez, Ingrid 
dc.contributor.authorFuentes, Ángel
dc.contributor.authorBallaz, Santiago
dc.contributor.authorObeso, José A.
dc.contributor.authorRodríguez, Manuel 
dc.contributor.otherCiencias Médicas Básicas
dc.contributor.otherGrupo de Neurobiología y Neurología Experimental
dc.date.accessioned2024-07-29T20:06:56Z
dc.date.available2024-07-29T20:06:56Z
dc.date.issued2012
dc.identifier.urihttp://riull.ull.es/xmlui/handle/915/38582
dc.description.abstractDespite evidence suggesting the interaction among glutamate (GLU), dopamine (DA) and ascorbic acid (AA) in the striatum, their actions are often studied separately. Microdialysis was used here to quantify the extracellular interaction among GLUeDAeAA in the striatum of rats, an interaction which was compared with those studied in the substantia nigra (SN). Perfusion of GLU by reverse microdialysis increased DA and decreased 3,4-dihydroxyphenylacetic acid (DOPAC) in the extracellular medium of the striatum, but increased both DA and DOPAC in the SN. The increase of extracellular DA-concentration induced by the local DA-perfusion decreased the extracellular level of GLU and glutamine, an effect that, as suggested by the GLU and glutamine increase observed after the haloperidol administration, probably involves the D2 dopamine receptor. Local administration of AA increased the extracellular DA, decreased DOPAC and had no effect on GLU and glutamine. Present data suggest that, in the striatum, GLU-release inhibits DA-uptake, DA-release inhibits GLU-release, and AA-release prevents DA-oxidation increasing its extracellular diffusion. These effects were different in the SN where GLU probably promoted the DA-release instead of inhibiting the DA-uptake as presumably occurred in the striatum. Present data denote a marked GLUeDAeAA interaction in the striatum, which might be relevant for the pharmacological control of basal ganglia disorders.en
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.relation.ispartofseriesNeuropharmacology 63 (2012) 1308e1314
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.titleStriatal interaction among dopamine, glutamate and ascorbate.en
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.neuropharm.2012.08.007
dc.subject.keywordGlutamateen
dc.subject.keywordDopamineen
dc.subject.keywordAscorbic aciden
dc.subject.keywordStriatumen
dc.subject.keywordParkinson’s diseaseen


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • DCCMM. Ciencias Médicas Básicas
    Documentos de investigación (artículos, libros, capítulos de libros, ponencias...) publicados por investigadores del Departamento de Ciencias Médicas Básicas

Mostrar el registro sencillo del ítem